https://stevenyiqingli.com/zh-hant/insights/ 經復核的制藥生產、技術轉移與國際合作產業文章。 zh-Hant https://stevenyiqingli.com/zh-hant/insights/technology-transfer-readiness-gaps.htmlhttps://stevenyiqingli.com/zh-hant/insights/technology-transfer-readiness-gaps.html從產品知識、分析方法、物料、設施和治理五個維度識別藥品技術轉移前的準備度缺口。Steven Li (李一青)Tue, 21 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/pharmaceutical-project-hold-no-go-criteria.htmlhttps://stevenyiqingli.com/zh-hant/insights/pharmaceutical-project-hold-no-go-criteria.html當證據、適配性、治理或時間尚不可控時，藥品委託生產項目應如何作出暫停決策。Steven Li (李一青)Tue, 21 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/sustainable-pharma-partnerships-southeast-asia.html https://stevenyiqingli.com/zh-hant/insights/sustainable-pharma-partnerships-southeast-asia.html 從市場、註冊、技術、質量與商務五個維度，構建東南亞醫藥合作的階段閘門框架。 Steven Li (李一青) Sun, 19 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/technology-transfer-localized-manufacturing.html https://stevenyiqingli.com/zh-hant/insights/technology-transfer-localized-manufacturing.html 以全生命週期方法推進制藥技術轉移、工藝放大、驗證與接收方能力建設。 Steven Li (李一青) Sun, 19 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/quality-systems-cross-border-partnerships.html https://stevenyiqingli.com/zh-hant/insights/quality-systems-cross-border-partnerships.html 以清晰的質量治理、證據體系和變更控制支持可持續的跨境醫藥合作。 Steven Li (李一青) Sun, 19 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/sterile-injectable-cmo-cdmo-project-evaluation.html https://stevenyiqingli.com/zh-hant/insights/sterile-injectable-cmo-cdmo-project-evaluation.html 從非保密適配篩選到技術轉移、驗證與商業化準備的階段化項目路徑。 Steven Li (李一青) Mon, 20 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/cmo-cdmo-technology-transfer-selection.html https://stevenyiqingli.com/zh-hant/insights/cmo-cdmo-technology-transfer-selection.html 根據產品成熟度、證據缺口、註冊責任和項目終態，選擇CMO、CDMO或技術轉移合作模式。 Steven Li (李一青) Mon, 20 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/pharmaceutical-quality-agreement-responsibilities.html https://stevenyiqingli.com/zh-hant/insights/pharmaceutical-quality-agreement-responsibilities.html 將質量治理、放行、變更、調查、記錄、審計和全生命週期管理轉化為可執行責任矩陣。 Steven Li (李一青) Mon, 20 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/cmo-cdmo-preliminary-assessment-nonconfidential-information.html https://stevenyiqingli.com/zh-hant/insights/cmo-cdmo-preliminary-assessment-nonconfidential-information.html 在披露敏感技術信息前，用一頁非保密事實安全判斷項目適配度。 Steven Li (李一青) Mon, 20 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/evaluating-sterile-pharmaceutical-contract-manufacturer.html https://stevenyiqingli.com/zh-hant/insights/evaluating-sterile-pharmaceutical-contract-manufacturer.html 圍繞無菌保證、場地適配、質量體系、證據和供應韌性的現場盡調框架。 Steven Li (李一青) Mon, 20 Jul 2026 00:00:00 +0000 https://stevenyiqingli.com/zh-hant/insights/due-diligence-chinese-pharmaceutical-manufacturing-partner.html https://stevenyiqingli.com/zh-hant/insights/due-diligence-chinese-pharmaceutical-manufacturing-partner.html 從公開記錄到現場審查，分階段核驗中國制藥合作主體、場地、產品和市場適配。 Steven Li (李一青) Mon, 20 Jul 2026 00:00:00 +0000